Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This clinical trial included two parts, Part A and Part B. The goal of Part A is to evaluate the safety and preliminary immunogenicity of the lyophilized herpes zoster virus mRNA vaccine (HZ mRNA vaccine) in healthy populations aged 40 years and older. The goal of Part B is to select the optimal dosage and schedule in healthy populations aged 50 years and older to support next further study.
Epistemonikos ID: f95ee150ad96fa4dc37ef6ff394f505bcfe191fe
First added on: Feb 11, 2026